Day: December 30, 2021

WALTHAM, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtually at the 40th Annual J.P. Morgan Healthcare conference being held January 10-13.  Tony J. Hunt, President and Chief Executive Officer, will present on Wednesday, January 12, 2022, at 9:45 a.m. EST. A live webcast of the presentation will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event. About Repligen Corporation Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological...

TORONTO, Dec. 30, 2021 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to provide a summary of the Company’s key 2021 accomplishments advancing the past-producing Beartrack-Arnett Gold Project (“Beartrack-Arnett”) located in Idaho, USA. HighlightsDrilling in five core holes for 2,400 meters continued to show promise on the main five-kilometer Beartrack-Arnett trend including the high-grade underground Joss target, which returned 4.34 g/t gold over 110.6 meters (including 12 g/t gold over 13.7 meters and 8.8 g/t gold over 11.8 meters1), one of the best intercepts ever reported on the project. 2021 results further defined high-grade mineralization which extends for more than one kilometer of strike at Joss and remains open on strike and at depth. All eighteen holes that...

Meet with InMed’s CEO Eric A. Adams, Shane Johnson, SVP and General Manager of BayMedica and Chris Meiering, VP of Commercial Operations VANCOUVER, British Columbia, Dec. 30, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, announces that InMed’s CEO Eric A. Adams, Shane Johnson, SVP and General Manager of BayMedica and Chris Meiering, VP of Commercial Operations will present at Tribe Public’s Webinar Presentation and Q&A Event titled “Addressing The Increasing Demand For Rare Cannabinoids.” The Event is scheduled to begin at 8am Pacific/11am Eastern on January 6, 2022. To register to join the complimentary, ZOOM webinar-based event, please visit Tribe Public LLC at INM22.TribePublic.com....

Toronto, Ontario, Dec. 30, 2021 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: CDCLF, FSE: 3ZQ0) (the “Company”), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 products in the medical and recreational market, is pleased to announce the results of voting at its annual general and special meeting of shareholders which was held on December 20, 2021 in Toronto, Ontario (the “Meeting”). All the resolutions, as described in the Company’s management information circular dated November 19, 2021, were approved by the requisite majority of votes cast at the Meeting. At the Meeting, the shareholders voted to: (i) fix the number of directors of the Company at five (5); (ii) reelect Igal Sudman, Roman...

An Emerging Markets Sponsored Commentary ORLANDO, Fla., Dec. 30, 2021 (GLOBE NEWSWIRE) — For those of you keeping an eye on the red-hot uranium sector, featured company Consolidated Uranium Inc. (“CUR”) (TSXV: CUR) (OTCQB: CURUF), a well-financed uranium company with a strategy of consolidating and advancing uranium projects around the globe, had a December to remember. We’ll get you up to speed in just a moment, but before we do kindly allow us a moment to point you to a recent article from the venerable Market Watch about uranium. Please click the headline below before returning to our update on Consolidated Uranium. Why spot uranium prices have climbed to a 6-year high Yep, six year highs. O.K., back to Consolidated Uranium which posted two news events in December alone that show this incredible opportunity. First...

Joint stock company “Olainfarm”, hereinafter referred to as – “the Company”, hereby informs that by decision No. 185 of 28th December 2021, the Financial and Capital Market Commission allowed AS “AB CITY”, registration number 40203174414, to carry out the Company’s  final share buy-back. Final buy-back price is 9,26 EUR per share. The value of one share has been calculated in accordance with Section 74, Paragraphs one, Clause 3 of the Financial Instruments Market Law. The entry date is the next working day after the date of publishing the information in the official gazette Latvijas Vēstnesis and it is 3rd January, 2022. The payment for shares will take place the next working day after the entry day, that is 4th January, 2022. The prospectus of the final share buy-back is available on the website of Nasdaq Riga or in Olaine at the...

VANCOUVER, British Columbia, Dec. 30, 2021 (GLOBE NEWSWIRE) — The holiday season is a special time of year. At Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company”) we use this time as an opportunity to reflect on the year that was, and, to design a road map aimed at achieving our goals in 2022. This time last year, we had concluded the 100% acquisition of the Sandman Gold Project (“Sandman” or the “Project”) from Newmont, located in Nevada. Since then, we increased the Sandman gold resource by 60%. Post the resource estimate increase, we have conducted significant additional work, including:Built a world class technical team of Nevada based geoscientists and developed relationships with local stakeholders Drilled 33 RC holes for total 5,804.9 m (19,045 ft), drilling hit both high grade and broad widths of gold...

The extra general meeting of Terranet AB (“Terranet” or the “Company”) was held today on the 30th of December 2021 and the following resolutions were passed by the meeting.  ELECTION OF THE BOARD OF DIRECTORS AND FEES TO THE BOARD OF DIRECTORS  The general meeting resolved that the board of directors shall consist of six directors without deputies. The directors Arne Hansson, Lars Novak and Michel Roig resigned.  Anders Blom, Magnus Edman, Nils Wollny and Tarek Shoeb were elected as directors.  The general meeting resolved that the fees to each director elected by the meeting and who is not employed by the company, or the group shall be SEK 100,000. The general meeting further resolved that each of the three members of the Company’s remuneration committee shall be entitled to a fee of SEK 25,000.  For the...